Key Details
Price
$23.68Last Dividend
$0.06Annual Revenue
$1.18 BAnnual EPS
$0.60Annual ROE
13.59%Beta
0.43Events Calendar
Next earnings date:
Mar 07, 2025Recent quarterly earnings:
Nov 05, 2024Recent annual earnings:
Mar 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
June 04, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with STVN included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
In the third quarter of 2024, sales were higher than expected, but adjusted EBITDA and EPS did not meet forecasts because of lower usage and increased costs in the Engineering division. Even with these short-term challenges, we anticipate better margins in the future due to valuable solutions and the opening of new facilities. Overall, we believe in long-term growth and have decided to keep our buy rating.
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a top global supplier of drug containment and delivery solutions for the pharmaceutical, biotechnology, and life sciences sectors, has announced its participation in three upcoming investor conferences. The company will take part in a fireside chat at the UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12, 2024, at 11:00 a.m. (PT). Additionally, the company will also make a presentation at another event.
Stevanato Group S.p.A. (NYSE:STVN) will hold its Q3 2024 earnings conference call on November 5, 2024, at 8:30 AM ET. The call will feature company representatives including Lisa Miles, Franco Stevanato, and Marco Dal Lago. Various analysts from different financial firms will also participate in the call.
Stevanato Group (STVN) reported quarterly earnings of $0.13 per share, matching the Zacks Consensus Estimate. This is a decrease from earnings of $0.16 per share from the same period last year.
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a top global provider of solutions for drug containment, delivery, and diagnostics in the pharmaceutical, biotechnology, and life sciences sectors, has announced that it will release its financial results for the third quarter of 2024 on Tuesday, November 5, 2024, at 6:30 a.m. (ET). The company will also hold a conference call and webcast at 8:30 a.m. (ET) on the same day to discuss the results.
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violations of federal securities laws.
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violations of federal securities laws.
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violations of federal securities laws.
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violations of federal securities laws.
FAQ
- What is the primary business of Stevanato Group SpA?
- What is the ticker symbol for Stevanato Group SpA?
- Does Stevanato Group SpA pay dividends?
- What sector is Stevanato Group SpA in?
- What industry is Stevanato Group SpA in?
- What country is Stevanato Group SpA based in?
- When did Stevanato Group SpA go public?
- Is Stevanato Group SpA in the S&P 500?
- Is Stevanato Group SpA in the NASDAQ 100?
- Is Stevanato Group SpA in the Dow Jones?
- When was Stevanato Group SpA's last earnings report?
- When does Stevanato Group SpA report earnings?